Extra Help 4rx
Managing Drug Costs in Medicare
Managing the costs of care, including prescription drug costs, is a major concern among family caregivers. Medicare beneficiaries enrolled in Part D, who have limited income and resources, may be eligible for Medicare’s Low Income Subsidy (also known as “LIS” or “Extra Help”) for prescription drug costs. LIS helps beneficiaries pay for annual deductibles, monthly premiums and copayments or coinsurance associated with Medicare Part D prescription drug plans.
NAC is proud to offer this virtual toolkit to help make family caregivers aware of this assistance for eligible Medicare Part D beneficiaries.
On this Page
“Extra Help” Toolkit
The Extra Help Toolkit is intended to help caregiving coalitions and advocates educate family caregivers in their communities about how to pay for medicines under the Medicare program. These materials may be downloaded or printed and shared with family caregivers, including use at local conferences, meetings, and public events. This toolkit was developed by NAC with grant support from Eli Lilly and Company.
To download, use and share any of the files listed above, please complete the form below.
“Extra Help” Pocket Card
A quick reference tool on applying for Medicare’s Low Income Subsidy that can be distributed to family caregivers
“Extra Help” Fact Sheet
A one-page overview of coverage and eligibility requirements for Medicare Low’s-Income Subsidy program
Stay engaged and get sample social media posts by bookmarking this page and following us using #ExtraHelp4Rx. Remember to tag @NAC4Caregiving in your posts.
Extra Help with Medicare Prescription Drug Plan Costs: What Help Can I Receive?
Understanding the Extra Help With Your Medicare Prescription Drug Plan
4 Ways to Help Lower Your Medicare Prescription Drug Costs”
How Medicare Drug Plans Use Pharmacies, Formularies, and Common Coverage Rules
Medicare Drug Coverage Under Medicare Part A, Part B, Part C & Part D
How Retiree Coverage Works With Medicare Prescription Drug Coverage
The ExtraHelp4Rx toolkit was developed by NAC with grant support from Eli Lilly and Company.